US Stock MarketDetailed Quotes

SNDX Syndax Pharmaceuticals

Watchlist
  • 15.570
  • +0.330+2.17%
Close Feb 26 16:00 ET
  • 14.830
  • -0.740-4.75%
Pre 05:37 ET
1.33BMarket Cap-4.28P/E (TTM)

About Syndax Pharmaceuticals Company

Syndax Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company engaged in the development of cancer therapies. Its product candidates include SNDX-5613 and SNDX-6352. The company was founded by Richard A. Heyman, Eckard Weber, Peter Ordentlich, Ronald M. Evans and Michael Downes on October 11, 2005 and is headquartered in Waltham, MA.

Company Profile

SymbolSNDX
Company NameSyndax Pharmaceuticals
Listing DateMar 3, 2016
Issue Price12.00
Founded2005
CEOMr. Michael A. Metzger
MarketNASDAQ
Employees184
Fiscal Year Ends12-31
Address35 Gatehouse Drive,Building D,3rd floor
CityWaltham
ProvinceMassachusetts
CountryUnited States of America
Zip Code02451
Phone1-781-419-1400
Websitehttp://www.syndax.com

Company Executives

  • Name
  • Position
  • Salary
  • Michael A. Metzger
  • Director and Chief Executive Officer
  • 9.13M
  • Keith A. Goldan
  • Chief Financial Officer
  • 2.83M
  • Steven Closter
  • Chief Commercial Officer
  • --
  • Dr. Neil Gallagher, M.D.
  • President and Head of Research and Development
  • 3.89M
  • Dennis G. Podlesak
  • Chairman of the Board
  • 1.10M
  • Dr. Aleksandra Rizo, M.D.,PhD
  • Director
  • --
  • Pierre Legault, C.P.A.,M.B.A.
  • Independent Director
  • 575.59K
  • Keith A. Katkin
  • Independent Director
  • 581.02K
  • Dr. Martin H. Huber, M.D.
  • Independent Director
  • 516.57K
  • Jennifer Ann Jarrett
  • Independent Director
  • 513.85K
  • William Meury
  • Independent Director
  • 500.27K
  • Luke J. Albrecht
  • General Counsel and Secretary
  • 2.59M

Trending Stocks

Top Gaining Chinese Stocks Top Gaining Chinese Stocks
No. Symbol % Chg
WANDA BEARING
920002
+30.00%
HENDERA
831152
+29.97%
LINGOOD
833284
+29.95%
4
WUHAN LAND
830779
+25.43%
5
TECHVISION
832876
+21.28%
Log In for the Full List
Unlock Now
Investment Course
Top 5 Industries for Stock Trading under Trump's Second Term
Stocks & Industries to Watch Under Trump's Second Presidency
With mooomoo, find out which stocks and industries may benefit from Trump's second presidency, based on his first administration's track record.
Reassessing Chinese Assets
Following the introduction of China's groundbreaking DeepSeek technology, Wall Street giants have revised their investment outlooks for the Chinese market.
Discussing
Big Tech’s earnings season in full swing! Nvidia is the only one left
On Thursday, $Amazon (AMZN.US)$ stock fell after the firm reported Q4 adjusted earnings of $1.86/share, vs estimates of $1.50/share, on reve Show More
AMZN earnings preview: Grab rewards by guessing the opening price!